Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199101000-00026PMID 1987687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence that the soluble interleukin 2 receptor level may determine the optimal time for cystoscopically-directed biopsy in pancreaticoduodenal allograft recipients.

  1990cited by this paper
• Human interleukin 6 and tumor necrosis factor alpha production studied at a single-cell level.

  1989cited by this paper
• Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.

  1989cited by this paper
• Increased plasma levels of interleukin-6 in sepsis.

  1989cited by this paper
• SEQUENTIAL DETERMINATIONS OF URINARY CYTOLOGY AND PLASMA AND URINARY LYMPHOKINES IN THE MANAGEMENT OF RENAL ALLOGRAFT RECIPIENTS

  1989cited by this paper
• Soluble interleukin-2 receptor level as an indicator of liver allograft rejection.

  1989cited by this paper
• RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN‐2, AND GAMMA‐INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS

  1989cited by this paper
• IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.

  1988cited by this paper
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

  1988cited by this paper
• Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2‐dependent cell line and preparation of anti‐IL 6 monoclonal antibodies

  1988cited by this paper
• Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.

  1988cited by this paper
• Molecular regulation of B lymphocyte response.

  1988cited by this paper
• Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression

  1987cited by this paper
• Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

  1987cited by this paper
• Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production.

  1987cited by this paper
• Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

  1987cited by this paper
• B cell growth modulating and differentiating activity of recombinant human 26‐kd protein (BSF‐2, HuIFN‐beta 2, HPGF).

  1987cited by this paper
• B-cell stimulatory factors (BSFs): Molecular structure, biological function, and regulation of expression

  1987cited by this paper
• Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

  1986cited by this paper
• Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

  1986cited by this paper
• Clinical and experimental studies with cyclosporine in renal transplantation.

  1985cited by this paper
• Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

  1985cited by this paper
• PHARMACODYNAMIC ASSESSMENT OF THE IN VIVO CYCLOSPORINE EFFECT ON INTERLEUKIN‐2 PRODUCTION BY LYMPHOCYTES IN KIDNEY TRANSPLANT RECIPIENTS

  1985cited by this paper
• The value of serial serum trough cyclosporine levels in human renal transplantation.

  1984cited by this paper
• Mechanisms of Rejection and Prolongation of Vascularized Organ Allografts

  1984cited by this paper
• Induction of cytotoxic T cell function requires sequential action of three different lymphokines.

  1983cited by this paper
• A human helper T cell clone secreting both killer helper factor(s) and T cell-replacing factor(s).

  1982cited by this paper
• Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules.

  1981cited by this paper

• Impact of interleukin‐6 on T cells in kidney transplant recipients

  2022cites this paper
• The relation between DNA methylation patterns and serum cytokine levels in community-dwelling adults: a preliminary study

  2017cites this paper
• Excretion of urinary proteins as predictors of early posttransplantation complications and late renal allograft failure

  2005influential citation
• Determinants of Clinical Course and Outcome of Puumala Hantavirus-induced Nephropathia Epidemica

  2003cites this paper
• Locally derived cytokines and upregulation of MHC class II genes in allografts.

  2002cites this paper
• Interleukin-6 in islet xenograft rejection

  2001cites this paper
• Interleukin‐6 in islet xenograft rejection

  2001cites this paper
• Methods for Clinical Monitoring of Cyclosporin in Transplant Patients

  2000cites this paper
• The role of C-reactive protein in graft dysfunction after renal transplantation.

  1999cites this paper
• Acute Kidney Graft Rejection Morphology and immunology

  1997cites this paper
• Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.

  1997cites this paper
• Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunction.

  1997cites this paper
• Molecular biology of cytokines.

  1996cites this paper
• The influence of the immunosuppressants OKT3 and ATG on immunological parameters.

  1996cites this paper
• Drug‐Cytokine Interactions: Focus on Cyclosporine

  1996cites this paper
• Serum HGF levels in acute renal rejection after living related renal transplantation

  1996cites this paper
• Determination of the presence of interleukin-6 in bile after orthotopic liver transplantation. Its role in the diagnosis of acute rejection.

  1996cites this paper
• Interleukin 6 in diseases: cause or cure?

  1996cites this paper
• Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.

  1996cites this paper
• Serum C-reactive protein. A useful and economical marker of immune activation in renal transplantation.

  1996cites this paper
• The paradox of cytokine monitoring-predictor of immunologic activity as well as immunologic silence following cardiac transplantation.

  1996cites this paper
• Soluble adhesion molecules in renal transplantation.

  1996cites this paper
• In situ expression of cytokines in human heart allografts.

  1996cites this paper
• Evaluation of serum IL-8 concentrations after orthotopic liver transplantation in rats.

  1995cites this paper
• Renal allograft histopathology.

  1995cites this paper
• Endothelin-1 increases intracellular calcium in human monocytes and causes production of interleukin-6.

  1995cites this paper
• Inflammatory cytokines in obstructive jaundice

  1994cites this paper
• Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice.

  1994cites this paper
• Cytokines in Clinical and Experimental Transplantation

  1994cites this paper
• Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity.

  1994cites this paper
• Evaluation of sequential serum interleukin-6 levels in liver allograft recipients.

  1994cites this paper
• IL-6, IL-8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro.

  1994cites this paper
• Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients.

  1994cites this paper
• Correlation of serum basic fetoprotein with acute rejection in kidney transplantation

  1994cites this paper
• The diagnostic value of GM‐CSF and IL‐6 determinations in patients after renal transplantation

  1994cites this paper
• IL‐6 INDEPENDENT MONOCYTE/B CELL DEFECT IN RENAL TRANSPLANT RECIPIENTS WITH LONG‐TERM STABLE GRAFT FUNCTION

  1994cites this paper
• Uncoupling of Airway Inflammation and Bronchial Hyperreactivity

  1994cites this paper
• Serum and urine IL-6 and TNF-alpha in renal transplant recipients with graft dysfunction.

  1993cites this paper
• [Expression of IL6 and TNF-alpha in normal and pathological kidney].

  1993cites this paper
• Interleukin‐6 and neopterin in renal transplant recipients: a longitudinal study

  1993cites this paper
• The cytokines: physiological and pathophysiological aspects.

  1993cites this paper
• Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study

  1993cites this paper
• Immunologic parameters for the diagnosis of graft rejection.

  1993cites this paper
• IN SITU PRODUCTION OF INTERLEUKIN‐6 WITHIN HUMAN LUNG ALLOGRAFTS DISPLAYING REJECTION OR CYTOMEGALOVIRUS PNEUMONIA

  1993cites this paper
• Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid.

  1993cites this paper
• Raised levels of tumor‐necrosis factor alpha (TNFα) in cardiac transplant patients

  1993cites this paper
• Comparison of fine-needle aspiration biopsy, Doppler ultrasound, and radionuclide scintigraphy in the diagnosis of acute allograft dysfunction in renal transplant recipients: sensitivity, specificity, and cost analysis.

  1993cites this paper
• Plasma GM-CSF, IL-6, and IL-3 monitoring allows differentiation between infection and rejection in some renal transplant recipients: preliminary results of a retrospective study.

  1993cites this paper
• Role of maintenance immunosuppression and methylprednisolone in OKT3-induced cytokine release.

  1992cites this paper
• [Rejection reaction. Elements of diagnosis, monitoring, therapeutic attitude in the case of kidney].

  1992cites this paper
• THE RELATIONSHIP OF SERUM IL‐6 LEVELS TO ACUTE GRAFT‐VERSUS‐HOST DISEASE AND HEPATORENAL DISEASE AFTER HUMAN BONE MARROW TRANSPLANTATION

  1992cites this paper
• Pharmacodynamic Monitoring of Cyclosporin

  1992cites this paper
• Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoring

  1992cites this paper
• The effect of IL-6 on the des-gamma-carboxy prothrombin synthesis in human hepatoma cells

  1992cites this paper
• Cytokines and their receptors: molecular mechanism of interleukin-6 gene repression by glucocorticoids.

  1992cites this paper
• Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantation.

  1992cites this paper
• The cytokine network and regulation of the immune response to organ transplants

  1992cites this paper
• BINDING OF PHYCOERYTHRIN‐CONJUGATED INTERLEUKIN‐6 TO IN VITRO‐ACTIVATED HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS—EFFECT OF IMMUNOSUPPRESSIVE AGENTS AND OF A CALCIUM CHANNEL BLOCKER

  1992cites this paper
• An increase in spontaneous proliferation of peripheral blood mononuclear cells in the early phase after liver transplantation--a useful indication of acute rejection.

  1992cites this paper
• Preliminary evidence that monitoring of plasma granulocyte-macrophage colony-stimulating factor may be helpful to differentiate between infection and rejection in renal transplant patients.

  1992cites this paper
• Cytokines and their receptors in transplantation.

  1991cites this paper